Navigation Links
Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information

Landmark Meeting Dec. 6, 2007 to Address FDA's Next Big Challenge

WASHINGTON, Oct. 17 /PRNewswire-USNewswire/ -- Is the Food and Drug Administration effectively communicating risk/safety information on drugs and devices to physicians and the public?

That's a key question a panel of experts will discuss and debate at a landmark Colloquium, Communicating Risk/Safety Information: How FDA Is Meeting the Challenge, sponsored by the Food and Drug Law Institute (FDLI), Dec. 6, 2007, in Washington, D.C.

This meeting is the third in a series of colloquia sponsored by FDLI. Under its new strategic direction, FDLI is committed to using the Colloquium series as a neutral forum to address the legal, regulatory, policy and practical implications of technological innovations affecting the food and drug industry.

As the public becomes more concerned about whether it's safe to take -- or stop -- their medications, FDA is making risk communication a top priority. The agency is forming an advisory committee on communication and implementing new Congressional requirements on risk evaluation. But it's unclear what that means for those who must deal with adverse events and contraindications every day.

Colloquium attendees will receive:

> Results of a study on how FDA handled the antidepressant drug controversy;

> Analysis of the new risk evaluation and mitigation strategy (REMS) requirements;

> Tips on developing world-class risk/safety and communications plans;

> Vital information on FDA's new Risk Communications Advisory Committee;

> An inside look at FDA's overall from communications strategy from its Deputy Commissioner and Chief Medical Officer Janet Woodcock, M.D.; and

> Excerpts from FDA's Response to the IOM's Report on Drug Safety.

The expert panel includes:

> Janet Woodcock, Deputy Commissioner & Chief Medical Officer, FDA;

> Randall W, Lutter, Deputy Commissioner for Policy & Planning, FDA;

> Stuart M. Pape, Managing Partner, Patton Boggs;

> Robert Dormer, Partner, Hyman Phelps & McNamara;

> Grace-Marie Turner, President, Galen Institute;

> Susan Newberry, Senior Vice President, Director, D.C Healthcare Practice,

Ketchum Communications; and

> Kelly Posner, Associate Professor, Columbia University.

Registration is $295 for FDLI members, $395 for non-members. Attendance is limited, so registrants are strongly urged to sign up early.

To register, visit or call (800) 956-6923 or (202) 371-1420.

Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field.

SOURCE Food & Drug Law Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Hundred million dollar gift for malaria institute
2. Magsaysay Award for Dr.Shanta from Chennai Cancer Institute
3. Ontario Institute for Cancer Research is funded $142 million
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
6. Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function
7. Georgia Institute of Technology develops doppler Vein finder
8. Germany Institutes Tough Measures To Tackle Bird Flu
9. MoH Considering Hiking Fees, Private Institutes Are Worried
10. Business model for Liver Institute cleared by Delhi Cabinet
11. Government to Open More Pharma Institutes Across India
Post Your Comments:
(Date:11/25/2015)... ... 2015 , ... Beddit® has launched a new Android app for ... features a more intuitive SleepScore™ that rates sleep quality on a 100-point scale and ... created by a proprietary algorithm. Beddit analyzes the data to provide an easy to ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... In an ... Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of ... and surgical intensive care units (totaling 30 beds) from May 2014 through October 2015 ...
(Date:11/25/2015)... ... ... Today, Mothers Against Drunk Driving (MADD) learned that the number of ... time since 2011. In 2014, there were 9,967 fatalities involving an alcohol impaired driver, ... Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in 2014. Drunk ...
(Date:11/25/2015)... Silver Spring, Md (PRWEB) , ... November 25, ... ... the Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups ... the history of this disease. The Periwinkle Pioneers, nominated by the public, will ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... announced that it has undertaken significant expansion of its current state of the ... is part of PharmaTech’s strategy to increase its manufacturing capacity as well as ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 3D ... by 2022, according to a new report by Grand View ... Kidney Disease (CKD) which demands kidney transplantation is expected to ... cost effective substitute for organ transplantation. --> 3D ... by 2022, according to a new report by Grand View ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
Breaking Medicine Technology: